Dr. Michelle Lea Dickerson, DNP, FNP-BC General Practice Medicare: Not Enrolled in Medicare Practice Location: 6372 Mechanicsville Tpke Ste 101, Mechanicsville, VA 23111 Phone: 804-522-1471 Fax: 804-522-1472 |
Dr. Bishoy T Samuel, MD General Practice Medicare: Medicare Enrolled Practice Location: 8220 Meadowbridge Rd Ste 310, Mechanicsville, VA 23116 Phone: 804-417-0120 Fax: 804-277-3029 |
News Archive
United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.
A new study published in the journal Pediatrics on Monday examined the risks of consumption of high-caffeine energy drinks on children and young adults. The study notes that these drinks are linked to an array of serious events like heart palpitations, high blood pressure and even cardiac arrest and death. The risk rises if young adults consuming the drink suffer from chronic diseases or take other medications.
Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).
Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia. Apligraf is a living cell based product used by physicians to heal chronic wounds in patients in the U.S. and around the world.
› Verified 7 days ago